EUPRAXIA PHARMACEUTICALS INC. Operating Lease Cost
EUPRAXIA PHARMACEUTICALS INC. (EPRX) reported Operating Lease Cost of $83.67 thousand for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2026-03-13
| Period end | Operating Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $83.67K 40-F · filed 2026-03-13 |
| 2024-12-31 | $65.74K 40-F · filed 2026-03-13 |
| 2023-12-31 | $65.00K 40-F · filed 2025-03-20 |
| 2022-12-31 | $67.42K 40-F · filed 2024-04-01 |